US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ultragenyx Pharmaceutical

35.69

+0.71002.03%

Post-market: 35.63-0.0600-0.17%16:31 EDT

Volume:690.76K

Turnover:24.54M

Market Cap:3.35B

PE:-5.68

High:35.74

Open:35.00

Low:34.74

Close:34.98

Loading ...

Overview Company News Filings

Ultragenyx posts trial data backing Phase 3 design for Angelman syndrome therapy

Ultragenyx Presents Positive Update on Gtx-102 Angelman Syndrome Program at Fast’s 17TH Annual Global Science Summit

THOMSON REUTERS

Ultragenyx Presents Positive Update on GTX-102 Angelman Syndrome Program at FAST’s 17th Annual Global Science Summit

Ultragenyx Pharmaceutical Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

CUMBERLAND PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG AND RARE PEDIATRIC DISEASE DESIGNATIONS FOR NEW TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

Ultragenyx Pharma Is Maintained at Buy by Canaccord Genuity

Ultragenyx Q3 Loss Narrower Than Expected, Revenues Beat Estimates

Bank of America Securities Sticks to Their Buy Rating for Ultragenyx Pharmaceutical (RARE)

Ultragenyx Pharma Price Target Maintained With a $116.00/Share by Cantor Fitzgerald

Stifel Nicolaus Reaffirms Their Buy Rating on Ultragenyx Pharmaceutical (RARE)

RBC Capital Sticks to Their Buy Rating for Ultragenyx Pharmaceutical (RARE)

Ultragenyx Pharmaceutical Inc : H.c. Wainwright Raises Target Price to $95 From $82

THOMSON REUTERS

Ultragenyx Pharma Is Maintained at Buy by HC Wainwright & Co.

Ultragenyx price target raised to $95 from $82 at H.C. Wainwright

Ultragenyx Pharmaceutical Inc (RARE) Q3 2024 Earnings Call Highlights: Robust Revenue Growth ...

Ultragenyx Pharmaceutical Inc : Jefferies Cuts Target Price to $124 From $129

THOMSON REUTERS

Ultragenyx Pharmaceutical: Promising Clinical Pipeline and Strong Growth Prospects Justify Buy Rating

Ultragenyx Pharmaceutical Inc reports results for the quarter ended in September 30 - Earnings Summary

Stock Track | Ultragenyx Stock Plunges Despite Earnings Beat on Disappointing Outlook

Ultragenyx (RARE) Reports Q3 Loss, Tops Revenue Estimates

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RARE/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"RARE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RARE\",,,,,undefined,":{"symbol":"RARE","market":"US","secType":"STK","nameCN":"Ultragenyx Pharmaceutical","latestPrice":35.69,"timestamp":1744920000000,"preClose":34.98,"halted":0,"volume":690760,"hourTrading":{"tag":"盘后","latestPrice":35.63,"preClose":35.69,"latestTime":"16:31 EDT","volume":16894,"amount":602725.71,"timestamp":1744921918885},"delay":0,"floatShares":90482798,"shares":93899667,"eps":-6.286667,"marketStatus":"Market Closed","change":0.71,"latestTime":"04-17 16:00:00 EDT","open":35,"high":35.74,"low":34.743,"amount":24540438.48872,"amplitude":0.028502,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.286667,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1391144400000,"exchange":"NASDAQ","adjPreClose":34.98,"preHourTrading":{"tag":"盘前","latestPrice":35.4,"preClose":34.98,"latestTime":"09:01 EDT","volume":14,"amount":487.88992,"timestamp":1744894864471},"postHourTrading":{"tag":"盘后","latestPrice":35.63,"preClose":35.69,"latestTime":"16:31 EDT","volume":16894,"amount":602725.71,"timestamp":1744921918885},"volumeRatio":0.6077252471086637,"impliedVol":0.1996,"impliedVolPercentile":0.0159},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RARE\",,,,,undefined,":{"symbol":"RARE","floatShares":90482798,"roa":"-22.37%","roe":"-211.71%","lyrEps":-6.286667,"volumeRatio":0.6077252471086637,"shares":93899667,"dividePrice":0,"high":35.74,"amplitude":0.028502,"preClose":34.98,"low":34.743,"week52Low":29.59,"pbRate":"13.13","psRate":"5.98","week52High":60.37,"institutionHeld":0,"latestPrice":35.69,"eps":-6.286667,"divideRate":0,"volume":690760,"delay":0,"ttmEps":-6.286667,"open":35,"prevYearClose":42.07,"prevWeekClose":34.14,"prevMonthClose":36.21,"prevQuarterClose":36.21,"fiveDayClose":33.16,"twentyDayClose":38.89,"sixtyDayClose":42.94},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RARE\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2482478224","title":"Ultragenyx posts trial data backing Phase 3 design for Angelman syndrome therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2482478224","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482478224?lang=en_us&edition=fundamental","pubTime":"2024-11-10 01:10","pubTimestamp":1731172206,"startTime":"0","endTime":"0","summary":"ShidlovskiUltragenyx Pharmaceutical (NASDAQ:RARE) announced Saturday that GTX-102, its candidate for the rare neuro-genetic disorder Angelman syndrome, improved patient outcomes across multiple domain","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/865692826/image_865692826.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/865692826/image_865692826.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4269681-ultragenyx-posts-data-angelman-syndrome-therapy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["QLD","PSQ","MNQmain","BK4139","TQQQ",".IXIC","RARE","NQmain","SQQQ","QID"],"gpt_icon":0},{"id":"2482557424","title":"Ultragenyx Presents Positive Update on Gtx-102 Angelman Syndrome Program at Fast’s 17TH Annual Global Science Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2482557424","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482557424?lang=en_us&edition=fundamental","pubTime":"2024-11-09 23:30","pubTimestamp":1731166203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241109:nTUAC3PTXH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2482932424","title":"Ultragenyx Presents Positive Update on GTX-102 Angelman Syndrome Program at FAST’s 17th Annual Global Science Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2482932424","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482932424?lang=en_us&edition=fundamental","pubTime":"2024-11-09 23:30","pubTimestamp":1731166200,"startTime":"0","endTime":"0","summary":"Phase 1/2 data show improvements across all domains and confirm that Phase 3 Aspire study is amply powered to establish efficacy of GTX-102 Phase 3 program on track to begin enrollment by end-of-year ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/09/2977959/20739/en/Ultragenyx-Presents-Positive-Update-on-GTX-102-Angelman-Syndrome-Program-at-FAST-s-17th-Annual-Global-Science-Summit.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4124","LU2517655374.HKD","BK4585","LU0154245673.USD","SMMF","IE00B19Z4B17.USD","BK4211","IT","BK4135","CNS","BK4567","FAST","LU2517655028.SGD","GTX","RARE","BK4104","IE00B66KJ199.SGD","IE0031619046.USD","BK4134","BK4139","LU1814569148.SGD","IE00B7SZL793.SGD","LU2517655291.USD","BK4588","LU0107464264.USD","LU0154245756.USD"],"gpt_icon":0},{"id":"2481903471","title":"Ultragenyx Pharmaceutical Third Quarter 2024 Earnings: Beats Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2481903471","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481903471?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:05","pubTimestamp":1730981105,"startTime":"0","endTime":"0","summary":"NasdaqGS:RARE Earnings and Revenue Growth November 7th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 3.1%. Earnings per share  also surpassed analyst estimates by 5.7%.Looking ahead, revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Biotechs industry in the US.The company's shares are down 2.5% from a week ago.Every company has them, and we've spotted   3 warning signs for Ultragenyx Pharmaceutical   you should know about.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ultragenyx-pharmaceutical-third-quarter-2024-120505280.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RARE"],"gpt_icon":0},{"id":"2481966423","title":"CUMBERLAND PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG AND RARE PEDIATRIC DISEASE DESIGNATIONS FOR NEW TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY","url":"https://stock-news.laohu8.com/highlight/detail?id=2481966423","media":"PR Newswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481966423?lang=en_us&edition=fundamental","pubTime":"2024-11-07 06:21","pubTimestamp":1730931660,"startTime":"0","endTime":"0","summary":"NASHVILLE, Tenn., Nov. 6, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. , a specialty pharmaceutical company, announced today that the United States  Food and Drug Administration  granted Orphan Drug Designation and Rare Pediatric Disease Designation to Ifetroban for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy . Cumberland is completing the FIGHT DMD trial, a multicenter, double-blind, placebo-controlled Phase II study investigating the pharmacokinetics, safety and efficacy of once daily oral Ifetroban in patients with DMD. Results will be announced later this year.\"For Duchenne muscular dystrophy, a devastating genetic disorder affecting young boys, securing both Orphan Drug and Rare Pediatric Disease Designations for Ifetroban from the FDA is a critical step forward,\" said A.J. Kazimi, chief executive officer of Cumberland Pharmaceuticals. \"These designations not only recognize the urgent need for effective treatments but also provide vital supp","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Z8HjfTeavBqH4AOjpvidSw--~B/aD04Mzt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/d6491f4600abd2c969a7073e33e75676","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Z8HjfTeavBqH4AOjpvidSw--~B/aD04Mzt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/d6491f4600abd2c969a7073e33e75676"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/cumberland-pharmaceuticals-receives-fda-orphan-222100374.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cumberland-pharmaceuticals-receives-fda-orphan-222100374.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DRUG","CPIX","BK4007","FOR","BK4139","BK4024","RARE","BK4557"],"gpt_icon":1},{"id":"2481939755","title":"Ultragenyx Pharma Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2481939755","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481939755?lang=en_us&edition=fundamental","pubTime":"2024-11-07 02:06","pubTimestamp":1730916360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RARE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 06, 2024 13:06 ET (18:06 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RARE"],"gpt_icon":0},{"id":"2481293810","title":"Ultragenyx Q3 Loss Narrower Than Expected, Revenues Beat Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2481293810","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481293810?lang=en_us&edition=fundamental","pubTime":"2024-11-06 22:42","pubTimestamp":1730904120,"startTime":"0","endTime":"0","summary":"Ultragenyx’s total revenues amounted to $139.5 million in the reported quarter, up 42% year over year. The top line surpassed the Zacks Consensus Estimate of $134 million on the back of higher product revenues.See the ZacksEarnings Calendar to stay ahead of market-making news.Crysvita’s total revenues were $97.8 million, up 31% year over year, driven by increased demand for approved indications. Crysvita’s net product revenues in thethird quarter of2024 were primarily aided by the $56 million generated from sales of the drug in the Latin America region and Turkey, representing 85% growth year over year.Mepsevii product revenues were $9.6 million in the third quarter, up 71% from the year-ago quarter. Dojolvi product revenues were $21.4 million, up 29%, driven by strong new patient demand. Evkeeza recorded sales of $10.7 million in the reported quarter.Year to date, shares of Ultragenyx have gained 9.1% against theindustry’s 3.8% decline.Cash, cash equivalents and marketable debt securi","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/.UMP6LIbiG0Pb3tKR9RYYw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1566882a22938942efee3e7508e93e96","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/.UMP6LIbiG0Pb3tKR9RYYw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1566882a22938942efee3e7508e93e96"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ultragenyx-q3-loss-narrower-expected-144200575.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVS","RARE"],"gpt_icon":1},{"id":"2481728988","title":"Bank of America Securities Sticks to Their Buy Rating for Ultragenyx Pharmaceutical (RARE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2481728988","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481728988?lang=en_us&edition=fundamental","pubTime":"2024-11-06 22:39","pubTimestamp":1730903979,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) today. The company’s ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-sticks-to-their-buy-rating-for-ultragenyx-pharmaceutical-rare?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-sticks-to-their-buy-rating-for-ultragenyx-pharmaceutical-rare?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RARE","BAC"],"gpt_icon":0},{"id":"2481398808","title":"Ultragenyx Pharma Price Target Maintained With a $116.00/Share by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2481398808","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481398808?lang=en_us&edition=fundamental","pubTime":"2024-11-06 22:38","pubTimestamp":1730903880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RARE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 06, 2024 09:38 ET (14:38 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RARE"],"gpt_icon":0},{"id":"2481069556","title":"Stifel Nicolaus Reaffirms Their Buy Rating on Ultragenyx Pharmaceutical (RARE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2481069556","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481069556?lang=en_us&edition=fundamental","pubTime":"2024-11-06 20:57","pubTimestamp":1730897853,"startTime":"0","endTime":"0","summary":"In a report released today, Dae Gon Ha from Stifel Nicolaus maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report), with a p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-buy-rating-on-ultragenyx-pharmaceutical-rare?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-buy-rating-on-ultragenyx-pharmaceutical-rare?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","RARE"],"gpt_icon":0},{"id":"2481608141","title":"RBC Capital Sticks to Their Buy Rating for Ultragenyx Pharmaceutical (RARE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2481608141","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481608141?lang=en_us&edition=fundamental","pubTime":"2024-11-06 20:19","pubTimestamp":1730895553,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Luca Issi maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) yesterday and set a price target of $77...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-buy-rating-for-ultragenyx-pharmaceutical-rare-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-buy-rating-for-ultragenyx-pharmaceutical-rare-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RARE"],"gpt_icon":0},{"id":"2481724766","title":"Ultragenyx Pharmaceutical Inc :  H.c. Wainwright Raises Target Price to $95 From $82","url":"https://stock-news.laohu8.com/highlight/detail?id=2481724766","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481724766?lang=en_us&edition=fundamental","pubTime":"2024-11-06 19:49","pubTimestamp":1730893797,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nFWN3MD16J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2481674260","title":"Ultragenyx Pharma Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2481674260","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481674260?lang=en_us&edition=fundamental","pubTime":"2024-11-06 19:32","pubTimestamp":1730892720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RARE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 06, 2024 06:32 ET (11:32 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RARE"],"gpt_icon":0},{"id":"2481671670","title":"Ultragenyx price target raised to $95 from $82 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2481671670","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481671670?lang=en_us&edition=fundamental","pubTime":"2024-11-06 19:15","pubTimestamp":1730891720,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Ultragenyx (RARE) to $95 from $82 and keeps a Buy rating on the shares post the Q3 report. The fi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ultragenyx-price-target-raised-to-95-from-82-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ultragenyx-price-target-raised-to-95-from-82-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2481464780","title":"Ultragenyx Pharmaceutical Inc (RARE) Q3 2024 Earnings Call Highlights: Robust Revenue Growth ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2481464780","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481464780?lang=en_us&edition=fundamental","pubTime":"2024-11-06 15:27","pubTimestamp":1730878071,"startTime":"0","endTime":"0","summary":"Total Revenue: $139 million for Q3 2024, representing 42% growth year-over-year.CRISPRIDA Revenue: $98 million, with $56 million from North America, $36 million from Latin America and Turkey, and $6 million from Europe.Operating Expenses: $271 million, including R&D expenses of $170 million and SG&A expenses of $80 million.Net Loss: $134 million or $1.40 per share for Q3 2024.Cash and Equivalents: $825 million as of September 30, 2024.Net Cash Used in Operations: $67 million for Q3 2024 and $335 million for the nine months ended September 30, 2024.2024 Revenue Guidance: Reaffirmed total revenue range of $530 million to $550 million.CRISPRIDA Full Year Revenue Expectation: Towards the upper end of $375 million to $400 million.GuruFocus has detected 4 Warning Signs with RARE.Ultragenyx Pharmaceutical Inc  reported a 42% year-over-year revenue growth for the third quarter of 2024, reaching $139 million.A: Emil Kakkis, President, CEO, and Director, explained that about 20% of Wilson patien","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/7FHEF4iYTpjeNgSMsWlKkg--~B/aD04MDt3PTE5MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/us.finance.gurufocus/7a27da4896a622e3aeb147e672407d33","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/7FHEF4iYTpjeNgSMsWlKkg--~B/aD04MDt3PTE5MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/us.finance.gurufocus/7a27da4896a622e3aeb147e672407d33"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ultragenyx-pharmaceutical-inc-rare-q3-072751317.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RARE"],"gpt_icon":0},{"id":"2481643119","title":"Ultragenyx Pharmaceutical Inc : Jefferies Cuts Target Price to $124 From $129","url":"https://stock-news.laohu8.com/highlight/detail?id=2481643119","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481643119?lang=en_us&edition=fundamental","pubTime":"2024-11-06 14:05","pubTimestamp":1730873131,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nFWN3MD0BQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2481612844","title":"Ultragenyx Pharmaceutical: Promising Clinical Pipeline and Strong Growth Prospects Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2481612844","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481612844?lang=en_us&edition=fundamental","pubTime":"2024-11-06 12:55","pubTimestamp":1730868916,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical (RARE – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Yaron ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ultragenyx-pharmaceutical-promising-clinical-pipeline-and-strong-growth-prospects-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ultragenyx-pharmaceutical-promising-clinical-pipeline-and-strong-growth-prospects-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RARE"],"gpt_icon":0},{"id":"2481611899","title":"Ultragenyx Pharmaceutical Inc reports results for the quarter ended in September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2481611899","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481611899?lang=en_us&edition=fundamental","pubTime":"2024-11-06 12:36","pubTimestamp":1730867811,"startTime":"0","endTime":"0","summary":"* Ultragenyx Pharmaceutical Inc    reported a quarterly adjusted loss of $1.40 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RARE"],"gpt_icon":0},{"id":"1188701061","title":"Stock Track | Ultragenyx Stock Plunges Despite Earnings Beat on Disappointing Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1188701061","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188701061?lang=en_us&edition=fundamental","pubTime":"2024-11-06 06:50","pubTimestamp":1730847030,"startTime":"0","endTime":"0","summary":"Shares of Ultragenyx Pharmaceutical Inc.  plummeted over 5% in after-hours trading on Tuesday, despite the company reporting better-than-expected third-quarter earnings and revenue results.For the quarter ended September 30, 2024, Ultragenyx reported a net loss of $1.40 per diluted share, narrower than the $2.23 loss in the same period a year ago and beating analysts' average estimate of a $1.48 loss. Revenue rose 42% year-over-year to $139.5 million, exceeding the consensus forecast of $135.3 m","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["RARE"],"gpt_icon":0},{"id":"2481661415","title":"Ultragenyx (RARE) Reports Q3 Loss, Tops Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2481661415","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481661415?lang=en_us&edition=fundamental","pubTime":"2024-11-06 06:15","pubTimestamp":1730844905,"startTime":"0","endTime":"0","summary":"Ultragenyx  came out with a quarterly loss of $1.40 per share versus the Zacks Consensus Estimate of a loss of $1.45. This compares to loss of $2.23 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 3.45%. A quarter ago, it was expected that this biotechnology company would post a loss of $1.64 per share when it actually produced a loss of $1.52, delivering a surprise of 7.32%.Ultragenyx , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $139.49 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 4.04%. This compares to year-ago revenues of $98.05 million. The company has topped consensus revenue estimates three times over the last four quarters.Ultragenyx shares have added about 6.8% since the beginning of the year versus the S&P 500's gain of 19.8%.While Ultragenyx has underperformed the market so far this year, the question tha","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/XFzKRSTb2_xUaLSOCP9.Bg--~B/aD02MDI7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a41b81fe729c761f3f94f42ff348f70c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/XFzKRSTb2_xUaLSOCP9.Bg--~B/aD02MDI7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a41b81fe729c761f3f94f42ff348f70c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ultragenyx-rare-reports-q3-loss-221505481.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RARE","AFMD"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":7,"totalSize":156,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RARE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-13","symbol":"RARE","fiscalQuarterEnding":"2024/12","expectedEps":-1.24,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739422800000,"reportTimeType":"post","actualEps":-1.39},{"market":"US","date":"2025-01-12","symbol":"RARE","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1736658000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-05","symbol":"RARE","fiscalQuarterEnding":"2024/09","expectedEps":-1.45,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730782800000,"reportTimeType":"post","actualEps":-1.4},{"market":"US","date":"2024-08-01","symbol":"RARE","fiscalQuarterEnding":"2024/06","expectedEps":-1.64,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"post","actualEps":-1.52},{"market":"US","date":"2024-05-02","symbol":"RARE","fiscalQuarterEnding":"2024/03","expectedEps":-1.72,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1714622400000,"reportTimeType":"post","actualEps":-2.03}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RARE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RARE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.65,"hold":0.05,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.65,"analysts":20,"updateTime":1718424000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RARE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RARE","date":"2025-04-17","current":-5.770746,"percent":0.721995,"low":-57.721347,"twenty":-17.163913,"median":-7.988725,"eighty":-5.047263,"high":-3.237111,"avg":-12.865912,"sd":11.21417,"marketCap":3284610351},"quantilePoints":[{"date":"2020-04-24","current":-9.724611,"twenty":-41.092415,"median":-18.981271,"eighty":-8.83789,"marketCap":3916363489},{"date":"2020-05-01","current":-8.687327,"twenty":-40.204873,"median":-18.786106,"eighty":-8.83563,"marketCap":3498621001},{"date":"2020-05-08","current":-8.975116,"twenty":-39.475183,"median":-18.615189,"eighty":-8.83563,"marketCap":3814388225},{"date":"2020-05-15","current":-10.022494,"twenty":-38.780307,"median":-18.202084,"eighty":-8.83563,"marketCap":4259519683},{"date":"2020-05-22","current":-10.376774,"twenty":-38.063001,"median":-18.066776,"eighty":-8.83563,"marketCap":4410087640},{"date":"2020-05-29","current":-9.624631,"twenty":-37.587435,"median":-17.87902,"eighty":-8.83563,"marketCap":4090429478},{"date":"2020-06-05","current":-9.829889,"twenty":-36.700172,"median":-17.213058,"eighty":-8.83563,"marketCap":4177663294},{"date":"2020-06-12","current":-9.568395,"twenty":-36.238943,"median":-16.91877,"eighty":-8.83563,"marketCap":4066529803},{"date":"2020-06-19","current":-10.996766,"twenty":-35.515997,"median":-16.449585,"eighty":-8.83563,"marketCap":4673581563},{"date":"2020-06-26","current":-10.766202,"twenty":-34.880062,"median":-16.047057,"eighty":-8.83563,"marketCap":4575592893},{"date":"2020-07-02","current":-12.096161,"twenty":-34.533174,"median":-15.914316,"eighty":-8.83563,"marketCap":5140820221},{"date":"2020-07-10","current":-12.127091,"twenty":-34.319178,"median":-15.750943,"eighty":-8.83563,"marketCap":5153965043},{"date":"2020-07-17","current":-12.073667,"twenty":-34.165471,"median":-15.682493,"eighty":-8.83563,"marketCap":5131260351},{"date":"2020-07-24","current":-10.933502,"twenty":-33.630411,"median":-15.442169,"eighty":-8.83563,"marketCap":4646694428},{"date":"2020-07-31","current":-15.713137,"twenty":-33.403837,"median":-15.274826,"eighty":-8.83563,"marketCap":4721939168},{"date":"2020-08-07","current":-17.056072,"twenty":-33.191014,"median":-15.274826,"eighty":-8.83563,"marketCap":5125503059},{"date":"2020-08-14","current":-17.110352,"twenty":-33.044701,"median":-15.274826,"eighty":-8.83563,"marketCap":5141814773},{"date":"2020-08-21","current":-17.602895,"twenty":-32.874882,"median":-15.274826,"eighty":-8.83563,"marketCap":5289828475},{"date":"2020-08-28","current":-17.226954,"twenty":-32.672148,"median":-15.274826,"eighty":-8.83563,"marketCap":5176854751},{"date":"2020-09-04","current":-15.240698,"twenty":-32.073958,"median":-15.261678,"eighty":-8.83563,"marketCap":4579966842},{"date":"2020-09-11","current":-14.842642,"twenty":-31.733969,"median":-15.200985,"eighty":-8.83563,"marketCap":4460347605},{"date":"2020-09-18","current":-16.660027,"twenty":-31.375759,"median":-15.200985,"eighty":-8.83563,"marketCap":5006487959},{"date":"2020-09-25","current":-16.499196,"twenty":-31.265773,"median":-15.200985,"eighty":-8.83563,"marketCap":4958156954},{"date":"2020-10-02","current":-16.967615,"twenty":-31.090702,"median":-15.200985,"eighty":-8.83563,"marketCap":5098921006},{"date":"2020-10-09","current":-18.988048,"twenty":-31.037306,"median":-15.200985,"eighty":-8.83563,"marketCap":5706079254},{"date":"2020-10-16","current":-18.489473,"twenty":-30.842003,"median":-15.200985,"eighty":-8.83563,"marketCap":5556253139},{"date":"2020-10-23","current":-18.708605,"twenty":-30.644242,"median":-15.200985,"eighty":-8.83563,"marketCap":5622104133},{"date":"2020-10-30","current":-25.673497,"twenty":-30.489754,"median":-15.200985,"eighty":-8.83563,"marketCap":6581657766},{"date":"2020-11-06","current":-28.752844,"twenty":-30.231689,"median":-15.200985,"eighty":-8.83563,"marketCap":7371079013},{"date":"2020-11-13","current":-30.249581,"twenty":-30.174442,"median":-15.200985,"eighty":-8.83563,"marketCap":7754782641},{"date":"2020-11-20","current":-29.514115,"twenty":-30.01147,"median":-15.200985,"eighty":-8.83563,"marketCap":7566238617},{"date":"2020-11-27","current":-31.591484,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":8098792791},{"date":"2020-12-04","current":-33.168219,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":8503004716},{"date":"2020-12-11","current":-37.402954,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9588621362},{"date":"2020-12-18","current":-43.364099,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":11116820295},{"date":"2020-12-24","current":-44.61052,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":11436352800},{"date":"2020-12-31","current":-35.722995,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9157947117},{"date":"2021-01-08","current":-38.860983,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9962401620},{"date":"2021-01-15","current":-35.604289,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9127515450},{"date":"2021-01-22","current":-36.249434,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9292904945},{"date":"2021-01-29","current":-35.764285,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9168532044},{"date":"2021-02-05","current":-41.8622,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":10731793551},{"date":"2021-02-12","current":-53.920829,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":10059793403},{"date":"2021-02-19","current":-53.160067,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9917861006},{"date":"2021-02-26","current":-50.791655,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9475995995},{"date":"2021-03-05","current":-42.523747,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7933485414},{"date":"2021-03-12","current":-45.556031,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":8499206525},{"date":"2021-03-19","current":-44.759384,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":8350579204},{"date":"2021-03-26","current":-38.985484,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":7273365868},{"date":"2021-04-01","current":-40.621841,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":7578654420},{"date":"2021-04-09","current":-37.133817,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6927907769},{"date":"2021-04-16","current":-39.014192,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7278721807},{"date":"2021-04-23","current":-39.42687,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7355713438},{"date":"2021-04-30","current":-40.376431,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7532869144},{"date":"2021-05-07","current":-37.945412,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7728797410},{"date":"2021-05-14","current":-36.736115,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7482485435},{"date":"2021-05-21","current":-35.563263,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7243596560},{"date":"2021-05-28","current":-33.697964,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6863668773},{"date":"2021-06-04","current":-30.543853,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6221233155},{"date":"2021-06-11","current":-33.697964,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6863668773},{"date":"2021-06-18","current":-31.448341,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6405461016},{"date":"2021-06-25","current":-31.087209,"twenty":-29.984017,"median":-15.161272,"eighty":-8.834973,"marketCap":6331904837},{"date":"2021-07-02","current":-31.213108,"twenty":-30.257731,"median":-15.161272,"eighty":-8.834973,"marketCap":6357548275},{"date":"2021-07-09","current":-30.262236,"twenty":-30.265324,"median":-15.161272,"eighty":-8.834973,"marketCap":6163872832},{"date":"2021-07-16","current":-28.271038,"twenty":-30.233301,"median":-15.161272,"eighty":-8.834973,"marketCap":5758301606},{"date":"2021-07-23","current":-27.406308,"twenty":-29.984017,"median":-15.161272,"eighty":-8.834973,"marketCap":5582171673},{"date":"2021-07-30","current":-26.44881,"twenty":-29.79768,"median":-15.161272,"eighty":-8.834973,"marketCap":5387146575},{"date":"2021-08-06","current":-17.083279,"twenty":-29.687102,"median":-15.161272,"eighty":-8.834973,"marketCap":6003491310},{"date":"2021-08-13","current":-17.901732,"twenty":-29.496644,"median":-15.161272,"eighty":-8.834973,"marketCap":6291116204},{"date":"2021-08-20","current":-15.473397,"twenty":-29.315394,"median":-15.15171,"eighty":-8.834973,"marketCap":5437738569},{"date":"2021-08-27","current":-18.1353,"twenty":-29.179331,"median":-15.15171,"eighty":-8.834973,"marketCap":6373197837},{"date":"2021-09-03","current":-19.766415,"twenty":-28.984947,"median":-15.15171,"eighty":-8.834973,"marketCap":6946412544},{"date":"2021-09-10","current":-19.629363,"twenty":-28.634625,"median":-15.15171,"eighty":-8.834973,"marketCap":6898248941},{"date":"2021-09-17","current":-18.969196,"twenty":-28.497709,"median":-15.15171,"eighty":-8.834973,"marketCap":6666249616},{"date":"2021-09-24","current":-18.359217,"twenty":-28.236842,"median":-15.15171,"eighty":-8.834973,"marketCap":6451887666},{"date":"2021-10-01","current":-16.948157,"twenty":-28.151413,"median":-15.15171,"eighty":-8.834973,"marketCap":5956006068},{"date":"2021-10-08","current":-15.759084,"twenty":-28.053185,"median":-15.15171,"eighty":-8.834973,"marketCap":5538135938},{"date":"2021-10-15","current":-15.442512,"twenty":-27.812745,"median":-15.15171,"eighty":-8.834973,"marketCap":5426884800},{"date":"2021-10-22","current":-15.098916,"twenty":-27.55852,"median":-15.082382,"eighty":-8.834973,"marketCap":5306136613},{"date":"2021-10-29","current":-16.199195,"twenty":-27.366816,"median":-15.082382,"eighty":-8.834973,"marketCap":5692802155},{"date":"2021-11-05","current":-15.975791,"twenty":-27.236045,"median":-15.082382,"eighty":-8.834973,"marketCap":5680639831},{"date":"2021-11-12","current":-15.43713,"twenty":-27.171258,"median":-15.082382,"eighty":-8.834973,"marketCap":5489103979},{"date":"2021-11-19","current":-15.205181,"twenty":-26.927437,"median":-15.06031,"eighty":-8.834973,"marketCap":5406627687},{"date":"2021-11-26","current":-14.662686,"twenty":-26.731524,"median":-14.936554,"eighty":-8.834973,"marketCap":5213728590},{"date":"2021-12-03","current":-14.570673,"twenty":-26.554402,"median":-14.855697,"eighty":-8.834973,"marketCap":5181010722},{"date":"2021-12-10","current":-14.932975,"twenty":-26.360162,"median":-14.855697,"eighty":-8.834973,"marketCap":5309837327},{"date":"2021-12-17","current":-16.265249,"twenty":-26.205264,"median":-14.855697,"eighty":-8.834973,"marketCap":5783564791},{"date":"2021-12-23","current":-16.244163,"twenty":-25.908959,"median":-14.855697,"eighty":-8.834973,"marketCap":5776066946},{"date":"2021-12-31","current":-16.119562,"twenty":-25.241061,"median":-14.855697,"eighty":-8.834973,"marketCap":5731761500},{"date":"2022-01-07","current":-14.145112,"twenty":-24.735967,"median":-14.855038,"eighty":-8.83563,"marketCap":5029690582},{"date":"2022-01-14","current":-13.811564,"twenty":-24.180303,"median":-14.806289,"eighty":-8.83563,"marketCap":4911088311},{"date":"2022-01-21","current":-12.876097,"twenty":-23.989848,"median":-14.747324,"eighty":-8.83563,"marketCap":4578456653},{"date":"2022-01-28","current":-12.651814,"twenty":-23.661155,"median":-14.661474,"eighty":-8.83563,"marketCap":4498706850},{"date":"2022-02-04","current":-13.154053,"twenty":-23.48091,"median":-14.600648,"eighty":-8.83563,"marketCap":4677291879},{"date":"2022-02-11","current":-10.94589,"twenty":-23.205637,"median":-14.505395,"eighty":-8.83563,"marketCap":4969707824},{"date":"2022-02-18","current":-10.194721,"twenty":-23.125145,"median":-14.35823,"eighty":-8.83563,"marketCap":4628658273},{"date":"2022-02-25","current":-10.307809,"twenty":-22.914219,"median":-14.283419,"eighty":-8.83563,"marketCap":4680003006},{"date":"2022-03-04","current":-9.594133,"twenty":-22.459434,"median":-14.16111,"eighty":-8.83563,"marketCap":4355976111},{"date":"2022-03-11","current":-9.996053,"twenty":-21.586553,"median":-14.118393,"eighty":-8.83563,"marketCap":4538458067},{"date":"2022-03-18","current":-10.663883,"twenty":-21.326675,"median":-14.069914,"eighty":-8.83563,"marketCap":4841669529},{"date":"2022-03-25","current":-10.524816,"twenty":-21.159681,"median":-13.968769,"eighty":-8.83563,"marketCap":4778529385},{"date":"2022-04-01","current":-11.823798,"twenty":-21.003206,"median":-13.863231,"eighty":-8.83563,"marketCap":5368299964},{"date":"2022-04-08","current":-12.514551,"twenty":-20.910296,"median":-13.803148,"eighty":-8.83563,"marketCap":5681919142},{"date":"2022-04-14","current":-13.050955,"twenty":-20.848103,"median":-13.773354,"eighty":-8.83563,"marketCap":5925459699},{"date":"2022-04-22","current":-11.470781,"twenty":-20.717776,"median":-13.670793,"eighty":-8.83563,"marketCap":5208021136},{"date":"2022-04-29","current":-10.878745,"twenty":-20.624785,"median":-13.564241,"eighty":-8.83563,"marketCap":4939222202},{"date":"2022-05-06","current":-8.557526,"twenty":-20.519008,"median":-13.487652,"eighty":-8.833003,"marketCap":4023783190},{"date":"2022-05-13","current":-7.654777,"twenty":-20.519008,"median":-13.402239,"eighty":-8.786823,"marketCap":3599306930},{"date":"2022-05-20","current":-7.220506,"twenty":-20.519008,"median":-13.35812,"eighty":-8.748709,"marketCap":3395110773},{"date":"2022-05-27","current":-7.233891,"twenty":-20.519008,"median":-13.323757,"eighty":-8.718034,"marketCap":3401404490},{"date":"2022-06-03","current":-7.645854,"twenty":-20.519008,"median":-13.277877,"eighty":-8.684283,"marketCap":3595111119},{"date":"2022-06-10","current":-7.418308,"twenty":-20.519008,"median":-13.17025,"eighty":-8.65258,"marketCap":3488117927},{"date":"2022-06-17","current":-7.925453,"twenty":-20.519008,"median":-13.057111,"eighty":-8.633594,"marketCap":3726579878},{"date":"2022-06-24","current":-9.008157,"twenty":-20.52732,"median":-13.025475,"eighty":-8.615488,"marketCap":4235671668},{"date":"2022-07-01","current":-9.317501,"twenty":-20.52732,"median":-12.971944,"eighty":-8.615488,"marketCap":4381126466},{"date":"2022-07-08","current":-9.836545,"twenty":-20.52732,"median":-12.903988,"eighty":-8.615488,"marketCap":4625182832},{"date":"2022-07-15","current":-9.62982,"twenty":-20.52732,"median":-12.867014,"eighty":-8.615488,"marketCap":4527979867},{"date":"2022-07-22","current":-7.657752,"twenty":-20.52732,"median":-12.683542,"eighty":-8.593044,"marketCap":3600705534},{"date":"2022-07-29","current":-7.375537,"twenty":-20.52732,"median":-12.576503,"eighty":-8.565198,"marketCap":3731564327},{"date":"2022-08-05","current":-7.696694,"twenty":-20.52732,"median":-12.447093,"eighty":-8.50432,"marketCap":3894049860},{"date":"2022-08-12","current":-7.138822,"twenty":-20.52732,"median":-12.354843,"eighty":-8.455092,"marketCap":3611801282},{"date":"2022-08-19","current":-6.78721,"twenty":-20.52732,"median":-12.331685,"eighty":-8.434672,"marketCap":3433907638},{"date":"2022-08-26","current":-6.852272,"twenty":-20.52732,"median":-12.331685,"eighty":-8.389678,"marketCap":3466824966},{"date":"2022-09-02","current":-6.61002,"twenty":-20.52732,"median":-12.331685,"eighty":-8.359036,"marketCap":3344260447},{"date":"2022-09-09","current":-6.816281,"twenty":-20.52732,"median":-12.331685,"eighty":-8.331801,"marketCap":3448615380},{"date":"2022-09-16","current":-6.371921,"twenty":-20.52732,"median":-12.331685,"eighty":-8.289414,"marketCap":3223797034},{"date":"2022-09-23","current":-5.744834,"twenty":-20.52732,"median":-12.331685,"eighty":-8.245615,"marketCap":2906530022},{"date":"2022-09-30","current":-5.732376,"twenty":-20.52732,"median":-12.331685,"eighty":-8.208124,"marketCap":2900226703},{"date":"2022-10-07","current":-5.25064,"twenty":-20.52732,"median":-12.331685,"eighty":-8.150659,"marketCap":2656498403},{"date":"2022-10-14","current":-5.130206,"twenty":-20.52732,"median":-12.331685,"eighty":-8.077486,"marketCap":2595566328},{"date":"2022-10-21","current":-5.328161,"twenty":-20.52732,"median":-12.331685,"eighty":-8.010065,"marketCap":2695719049},{"date":"2022-10-28","current":-5.642396,"twenty":-20.52732,"median":-12.331685,"eighty":-7.967887,"marketCap":2854702739},{"date":"2022-11-04","current":-3.646694,"twenty":-20.52732,"median":-12.331685,"eighty":-7.881082,"marketCap":2472626416},{"date":"2022-11-11","current":-3.779038,"twenty":-20.52732,"median":-12.331685,"eighty":-7.854126,"marketCap":2562361653},{"date":"2022-11-18","current":-3.721138,"twenty":-20.52732,"median":-12.331685,"eighty":-7.7969,"marketCap":2523102487},{"date":"2022-11-25","current":-3.693221,"twenty":-20.52732,"median":-12.331685,"eighty":-7.738619,"marketCap":2504173960},{"date":"2022-12-02","current":-4.153323,"twenty":-20.52732,"median":-12.331685,"eighty":-7.69117,"marketCap":2816144121},{"date":"2022-12-09","current":-4.202952,"twenty":-20.52732,"median":-12.331685,"eighty":-7.649461,"marketCap":2849794835},{"date":"2022-12-16","current":-4.717852,"twenty":-20.52732,"median":-12.331685,"eighty":-7.588745,"marketCap":3198920992},{"date":"2022-12-23","current":-4.499692,"twenty":-20.52732,"median":-12.331685,"eighty":-7.55634,"marketCap":3050998062},{"date":"2022-12-30","current":-4.790228,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":3247994949},{"date":"2023-01-06","current":-4.824348,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":3271129815},{"date":"2023-01-13","current":-4.502794,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":3053101231},{"date":"2023-01-20","current":-4.383891,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":2972479729},{"date":"2023-01-27","current":-4.520371,"twenty":-20.52732,"median":-12.331685,"eighty":-7.419224,"marketCap":3065019192},{"date":"2023-02-03","current":-4.728192,"twenty":-20.52732,"median":-12.331685,"eighty":-7.265696,"marketCap":3205931557},{"date":"2023-02-10","current":-4.549321,"twenty":-20.52732,"median":-12.331685,"eighty":-7.228067,"marketCap":3084648776},{"date":"2023-02-17","current":-4.834822,"twenty":-20.52732,"median":-12.331685,"eighty":-7.193971,"marketCap":3420254921},{"date":"2023-02-24","current":-4.342506,"twenty":-20.52732,"median":-12.331685,"eighty":-7.118611,"marketCap":3071980143},{"date":"2023-03-03","current":-4.536058,"twenty":-20.52732,"median":-12.331685,"eighty":-7.091607,"marketCap":3208902687},{"date":"2023-03-10","current":-3.847212,"twenty":-20.52732,"median":-12.331685,"eighty":-7.007538,"marketCap":2721598865},{"date":"2023-03-17","current":-3.824383,"twenty":-20.52732,"median":-12.331685,"eighty":-6.964752,"marketCap":2705449027},{"date":"2023-03-24","current":-3.740015,"twenty":-20.52732,"median":-12.331685,"eighty":-6.882782,"marketCap":2645764841},{"date":"2023-03-31","current":-3.980217,"twenty":-20.519008,"median":-12.327325,"eighty":-6.84769,"marketCap":2815689228},{"date":"2023-04-06","current":-3.845227,"twenty":-20.519008,"median":-12.327325,"eighty":-6.817229,"marketCap":2720194531},{"date":"2023-04-14","current":-3.834309,"twenty":-20.52732,"median":-12.331685,"eighty":-6.790561,"marketCap":2712470696},{"date":"2023-04-21","current":-4.095356,"twenty":-20.52732,"median":-12.331685,"eighty":-6.741883,"marketCap":2897140588},{"date":"2023-04-28","current":-4.242476,"twenty":-20.52732,"median":-12.331685,"eighty":-6.708105,"marketCap":3001216442},{"date":"2023-05-05","current":-4.503028,"twenty":-20.52732,"median":-12.331685,"eighty":-6.653176,"marketCap":3238005775},{"date":"2023-05-12","current":-4.638891,"twenty":-20.543943,"median":-12.127091,"eighty":-6.641982,"marketCap":3335701281},{"date":"2023-05-19","current":-5.014059,"twenty":-20.543943,"median":-12.030107,"eighty":-6.608226,"marketCap":3605474618},{"date":"2023-05-26","current":-4.91559,"twenty":-20.543943,"median":-11.942999,"eighty":-6.574925,"marketCap":3534667968},{"date":"2023-06-02","current":-4.885064,"twenty":-20.543943,"median":-11.851539,"eighty":-6.547631,"marketCap":3512717906},{"date":"2023-06-09","current":-5.079049,"twenty":-20.543943,"median":-11.661746,"eighty":-6.51973,"marketCap":3652207007},{"date":"2023-06-16","current":-4.811212,"twenty":-20.543943,"median":-11.483123,"eighty":-6.479975,"marketCap":3459612919},{"date":"2023-06-21","current":-4.936268,"twenty":-20.510696,"median":-11.421308,"eighty":-6.417082,"marketCap":3549537364},{"date":"2023-06-30","current":-4.593595,"twenty":-20.487227,"median":-11.238841,"eighty":-6.371161,"marketCap":3303130222},{"date":"2023-07-07","current":-4.482325,"twenty":-20.498962,"median":-11.187498,"eighty":-6.365701,"marketCap":3223118708},{"date":"2023-07-21","current":-4.237136,"twenty":-19.951513,"median":-11.097535,"eighty":-6.330057,"marketCap":3046810149},{"date":"2023-07-28","current":-4.134728,"twenty":-19.945557,"median":-11.07773,"eighty":-6.267685,"marketCap":2973171233},{"date":"2023-08-04","current":-4.057384,"twenty":-19.897508,"median":-11.023587,"eighty":-6.244893,"marketCap":2924314645},{"date":"2023-08-11","current":-3.621915,"twenty":-19.755822,"median":-10.996766,"eighty":-6.219342,"marketCap":2610455224},{"date":"2023-08-18","current":-3.463233,"twenty":-19.719512,"median":-10.937719,"eighty":-6.110593,"marketCap":2496086977},{"date":"2023-08-25","current":-3.666544,"twenty":-19.634346,"median":-10.899761,"eighty":-5.986933,"marketCap":2642621293},{"date":"2023-09-01","current":-3.648692,"twenty":-19.538575,"median":-10.863505,"eighty":-5.82457,"marketCap":2629754865},{"date":"2023-09-08","current":-4.080109,"twenty":-19.362208,"median":-10.802755,"eighty":-5.750563,"marketCap":2940693535},{"date":"2023-09-15","current":-3.893658,"twenty":-19.077218,"median":-10.732491,"eighty":-5.672427,"marketCap":2806310846},{"date":"2023-09-22","current":-3.630841,"twenty":-18.981061,"median":-10.679378,"eighty":-5.619716,"marketCap":2616888437},{"date":"2023-09-29","current":-3.488027,"twenty":-18.845186,"median":-10.612101,"eighty":-5.581034,"marketCap":2513957016},{"date":"2023-10-06","current":-3.468192,"twenty":-18.69861,"median":-10.535971,"eighty":-5.490331,"marketCap":2499660985},{"date":"2023-10-13","current":-3.237111,"twenty":-18.632497,"median":-10.521807,"eighty":-5.460417,"marketCap":2333112226},{"date":"2023-10-20","current":-3.7042,"twenty":-18.632497,"median":-10.443907,"eighty":-5.405085,"marketCap":2669761173},{"date":"2023-10-27","current":-3.893405,"twenty":-18.654427,"median":-10.382839,"eighty":-5.365218,"marketCap":2806128470},{"date":"2023-11-03","current":-4.68465,"twenty":-18.654427,"median":-10.364295,"eighty":-5.28414,"marketCap":2976073660},{"date":"2023-11-10","current":-4.517051,"twenty":-18.654427,"median":-10.342873,"eighty":-5.170628,"marketCap":2869601414},{"date":"2023-11-17","current":-5.034024,"twenty":-18.654427,"median":-10.305516,"eighty":-5.093229,"marketCap":3198025038},{"date":"2023-11-24","current":-5.058581,"twenty":-18.654427,"median":-10.281065,"eighty":-5.066839,"marketCap":3213625160},{"date":"2023-12-01","current":-5.0211,"twenty":-18.654427,"median":-10.19999,"eighty":-5.05703,"marketCap":3189814448},{"date":"2023-12-08","current":-5.353255,"twenty":-18.644324,"median":-10.171258,"eighty":-5.057805,"marketCap":3400826626},{"date":"2023-12-15","current":-5.933557,"twenty":-18.644324,"median":-10.119914,"eighty":-5.057805,"marketCap":3769482144},{"date":"2023-12-22","current":-5.885737,"twenty":-18.644324,"median":-10.02608,"eighty":-5.057805,"marketCap":3739102959},{"date":"2023-12-29","current":-6.238571,"twenty":-18.654427,"median":-9.99662,"eighty":-5.05703,"marketCap":3963252082},{"date":"2024-01-05","current":-6.086064,"twenty":-18.664531,"median":-9.939328,"eighty":-5.056254,"marketCap":3866367113},{"date":"2024-01-12","current":-5.964576,"twenty":-18.664531,"median":-9.900378,"eighty":-5.056254,"marketCap":3789187561},{"date":"2024-01-19","current":-5.578138,"twenty":-18.674634,"median":-9.811733,"eighty":-5.055479,"marketCap":3543690902},{"date":"2024-01-26","current":-5.848257,"twenty":-18.664531,"median":-9.7849,"eighty":-5.056254,"marketCap":3715292246},{"date":"2024-02-02","current":-5.699627,"twenty":-18.664531,"median":-9.642907,"eighty":-5.056254,"marketCap":3620870454},{"date":"2024-02-09","current":-5.874105,"twenty":-18.664531,"median":-9.594133,"eighty":-5.056254,"marketCap":3731713427},{"date":"2024-02-16","current":-6.261086,"twenty":-18.664531,"median":-9.561842,"eighty":-5.056254,"marketCap":3798219211},{"date":"2024-02-23","current":-6.634206,"twenty":-18.664531,"median":-9.488533,"eighty":-5.056254,"marketCap":4024568380},{"date":"2024-03-01","current":-7.019664,"twenty":-18.654427,"median":-9.448218,"eighty":-5.05703,"marketCap":4258401731},{"date":"2024-03-08","current":-6.901583,"twenty":-18.618504,"median":-9.331505,"eighty":-5.05703,"marketCap":4186769683},{"date":"2024-03-15","current":-6.331541,"twenty":-18.555722,"median":-9.248631,"eighty":-5.05703,"marketCap":3840959798},{"date":"2024-03-22","current":-6.331541,"twenty":-18.362305,"median":-9.119934,"eighty":-5.05703,"marketCap":3840959798},{"date":"2024-03-28","current":-6.354614,"twenty":-18.110177,"median":-9.054151,"eighty":-5.05703,"marketCap":3854956865},{"date":"2024-04-05","current":-6.389903,"twenty":-17.885675,"median":-8.975116,"eighty":-5.056254,"marketCap":3876364143},{"date":"2024-04-12","current":-6.881225,"twenty":-17.643907,"median":-8.928874,"eighty":-5.056254,"marketCap":4174419330},{"date":"2024-04-19","current":-5.887723,"twenty":-17.405641,"median":-8.865305,"eighty":-5.056254,"marketCap":3571722102},{"date":"2024-04-26","current":-5.951513,"twenty":-17.24545,"median":-8.784804,"eighty":-5.05703,"marketCap":3610419874},{"date":"2024-05-03","current":-5.85531,"twenty":-17.111877,"median":-8.730843,"eighty":-5.05703,"marketCap":3591360331},{"date":"2024-05-10","current":-5.582669,"twenty":-17.109146,"median":-8.602772,"eighty":-5.05703,"marketCap":3424135754},{"date":"2024-05-17","current":-5.770925,"twenty":-17.109146,"median":-8.502293,"eighty":-5.05703,"marketCap":3539602729},{"date":"2024-05-24","current":-5.403894,"twenty":-17.109146,"median":-8.437742,"eighty":-5.05703,"marketCap":3314483663},{"date":"2024-05-31","current":-5.234599,"twenty":-17.109146,"median":-8.326018,"eighty":-5.05703,"marketCap":3210646455},{"date":"2024-06-07","current":-5.657159,"twenty":-17.109146,"median":-8.22856,"eighty":-5.05703,"marketCap":3469824125},{"date":"2024-06-14","current":-6.362758,"twenty":-17.109548,"median":-8.139615,"eighty":-5.056254,"marketCap":3902604231},{"date":"2024-06-21","current":-5.610206,"twenty":-17.10995,"median":-8.062414,"eighty":-5.055479,"marketCap":3441025345},{"date":"2024-06-28","current":-6.111908,"twenty":-17.111877,"median":-7.980946,"eighty":-5.053152,"marketCap":3748744602},{"date":"2024-07-05","current":-5.933361,"twenty":-17.111877,"median":-7.91653,"eighty":-5.053152,"marketCap":3639232749},{"date":"2024-07-12","current":-6.476379,"twenty":-17.111877,"median":-7.842615,"eighty":-5.053152,"marketCap":3972293592},{"date":"2024-07-15","current":-6.660828,"twenty":-17.111877,"median":-7.815809,"eighty":-5.053152,"marketCap":4085425672},{"date":"2024-08-02","current":-6.829058,"twenty":-17.121885,"median":-7.700275,"eighty":-5.034024,"marketCap":3995825065},{"date":"2024-08-09","current":-7.915825,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":4631715386},{"date":"2024-08-16","current":-8.142486,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":4764339569},{"date":"2024-08-23","current":-8.871265,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":5190763157},{"date":"2024-08-30","current":-8.965707,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":5246023233},{"date":"2024-09-06","current":-8.885431,"twenty":-17.121885,"median":-7.70624,"eighty":-5.034024,"marketCap":5199052169},{"date":"2024-09-13","current":-9.102648,"twenty":-17.121885,"median":-7.774964,"eighty":-5.034024,"marketCap":5326150344},{"date":"2024-09-20","current":-9.252181,"twenty":-17.121885,"median":-7.849896,"eighty":-5.034024,"marketCap":5413645465},{"date":"2024-09-27","current":-8.691824,"twenty":-17.121885,"median":-7.916177,"eighty":-5.034024,"marketCap":5085769012},{"date":"2024-10-04","current":-8.446275,"twenty":-17.121885,"median":-7.994412,"eighty":-5.034024,"marketCap":4942092814},{"date":"2024-10-11","current":-8.47933,"twenty":-17.121885,"median":-8.063851,"eighty":-5.034024,"marketCap":4961433841},{"date":"2024-10-18","current":-8.9358,"twenty":-17.121885,"median":-8.144847,"eighty":-5.034024,"marketCap":5228524209},{"date":"2024-10-25","current":-8.628863,"twenty":-17.121885,"median":-8.21254,"eighty":-5.034024,"marketCap":5048928962},{"date":"2024-10-31","current":-8.1598,"twenty":-17.121885,"median":-8.258605,"eighty":-5.034024,"marketCap":4774470583},{"date":"2024-11-08","current":-8.324768,"twenty":-17.142899,"median":-8.319439,"eighty":-5.03169,"marketCap":4653445648},{"date":"2024-11-15","current":-7.864207,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4395997435},{"date":"2024-11-22","current":-7.596785,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4246511376},{"date":"2024-11-29","current":-7.862556,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4395074682},{"date":"2024-12-06","current":-7.814684,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4368314832},{"date":"2024-12-13","current":-7.7404,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4326790927},{"date":"2024-12-20","current":-7.175841,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4011209247},{"date":"2024-12-27","current":-7.233618,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4043505617},{"date":"2025-01-03","current":-6.792866,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":3797130446},{"date":"2025-01-10","current":-7.205555,"twenty":-17.163913,"median":-8.328682,"eighty":-5.029355,"marketCap":4027818809},{"date":"2025-01-17","current":-6.743343,"twenty":-17.163913,"median":-8.303187,"eighty":-5.029355,"marketCap":3769447843},{"date":"2025-01-24","current":-7.403646,"twenty":-17.163913,"median":-8.22856,"eighty":-5.029355,"marketCap":4138549223},{"date":"2025-01-31","current":-7.164286,"twenty":-17.163913,"median":-8.210902,"eighty":-5.029355,"marketCap":4004749973},{"date":"2025-02-07","current":-7.557166,"twenty":-17.163913,"median":-8.156652,"eighty":-5.029355,"marketCap":4224365294},{"date":"2025-02-14","current":-7.055416,"twenty":-17.163913,"median":-8.140574,"eighty":-5.029355,"marketCap":4015823014},{"date":"2025-02-21","current":-7.228695,"twenty":-17.163913,"median":-8.07435,"eighty":-5.029355,"marketCap":4114450084},{"date":"2025-02-28","current":-6.82078,"twenty":-17.163913,"median":-8.063851,"eighty":-5.029355,"marketCap":3882272258},{"date":"2025-03-07","current":-6.503875,"twenty":-17.184926,"median":-8.040838,"eighty":-5.027021,"marketCap":3701895062},{"date":"2025-03-14","current":-6.378738,"twenty":-17.184926,"median":-8.040838,"eighty":-5.027021,"marketCap":3630669195},{"date":"2025-03-21","current":-6.320232,"twenty":-17.184926,"median":-8.040838,"eighty":-5.048263,"marketCap":3597368790},{"date":"2025-03-28","current":-6.320232,"twenty":-17.184926,"median":-8.040838,"eighty":-5.048263,"marketCap":3597368790},{"date":"2025-04-04","current":-5.709174,"twenty":-17.184926,"median":-8.040838,"eighty":-5.048263,"marketCap":3249564556},{"date":"2025-04-11","current":-5.389018,"twenty":-17.163913,"median":-8.038932,"eighty":-5.047263,"marketCap":3067337338},{"date":"2025-04-17","current":-5.770746,"twenty":-17.163913,"median":-7.988725,"eighty":-5.047263,"marketCap":3284610351}],"updateTime":1745050115292}}}